EP 1441755 A2 20040804 - TOPICAL USE OF CYTOKINES AND CHEMOKINES FOR THE TREATMENT OF VIRAL OR MYKOTIC SKIN DISEASES OR TUMORAL DISEASES
Title (en)
TOPICAL USE OF CYTOKINES AND CHEMOKINES FOR THE TREATMENT OF VIRAL OR MYKOTIC SKIN DISEASES OR TUMORAL DISEASES
Title (de)
TOPIKALE VERWENDUNG VON CYTOKINEN UND/ODER CHEMOKINEN ZUR BEHANDLUNG VON VIRALEN ODER MYKOTISCHEN HAUTERKRANKUNGEN ODER TUMORERKRANKUNGEN
Title (fr)
UTILISATION TOPIQUE DE CYTOKINES ET CHIMIOKINES DANS LE TRAITEMENT DE MALADIES CUTANEES OU TUMORALES VIRALES OU MYCOTIQUES
Publication
Application
Priority
- DE 10154579 A 20011107
- EP 0212438 W 20021107
Abstract (en)
[origin: WO03039444A2] The invention relates to the use of at least one cytokine and/or chemokine in the production of a topically acting medicament for treating viral and/or mykotic skin diseases and/or tumoral diseases.
IPC 1-7
IPC 8 full level
A61K 9/06 (2006.01); A61K 9/00 (2006.01); A61K 9/12 (2006.01); A61K 38/00 (2006.01); A61K 38/19 (2006.01); A61K 38/21 (2006.01); A61K 47/00 (2006.01); A61K 47/10 (2006.01); A61K 47/44 (2006.01); A61P 17/00 (2006.01); A61P 31/10 (2006.01); A61P 31/12 (2006.01); A61P 35/00 (2006.01); A61K 47/06 (2006.01); A61K 47/20 (2006.01); A61K 47/28 (2006.01)
CPC (source: EP US)
A61K 9/0014 (2013.01 - EP US); A61K 38/063 (2013.01 - EP); A61K 38/19 (2013.01 - US); A61K 38/193 (2013.01 - EP); A61K 38/385 (2013.01 - EP); A61P 17/00 (2017.12 - EP); A61P 31/10 (2017.12 - EP); A61P 31/12 (2017.12 - EP); A61P 35/00 (2017.12 - EP); A61K 47/06 (2013.01 - EP US); A61K 47/10 (2013.01 - EP US); A61K 47/20 (2013.01 - EP US); A61K 47/28 (2013.01 - EP US)
Citation (search report)
See references of WO 03039444A2
Designated contracting state (EPC)
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR IE IT LI LU MC NL PT SE SK TR
DOCDB simple family (publication)
WO 03039444 A2 20030515; WO 03039444 A3 20031113; WO 03039444 B1 20031218; CA 2474196 A1 20030515; DE 10154579 A1 20030528; EP 1441755 A2 20040804; JP 2005512989 A 20050512; US 2005008614 A1 20050113
DOCDB simple family (application)
EP 0212438 W 20021107; CA 2474196 A 20021107; DE 10154579 A 20011107; EP 02796544 A 20021107; JP 2003541736 A 20021107; US 49388404 A 20040903